Effect of atenolol on aldosterone/renin ratio calculated by both plasma renin activity and direct renin concentration in healthy male volunteers

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3201-3206

  Ahmed, Ashraf H ^a   Gordon, Richard D ^a   Taylor, Paul ^a   Ward, Gregory ^b   Pimenta, Eduardo ^a   Stowasser, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ATENOLOL; CREATININE; ELECTROLYTE; HYDROCORTISONE; RENIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTROLYTE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; BLOOD; DRUG EFFECT; NONPARAMETRIC TEST; URINE;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE; ATENOLOL; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; HUMANS; HYDROCORTISONE; MALE; RENIN; STATISTICS, NONPARAMETRIC; TANDEM MASS SPECTROMETRY;

EID: 77954911237     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0225     Document Type: Article

References (36)

1. Stowasser M, Gordon RD 2003 Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 17:591-605
2. Kaplan NM 1969 Commentary on incidence of primary aldosteronism: current estimations based on objective data. Arch Intern Med 123:152-154
3. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318 (Pubitemid 24201225)
4. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM 2000 High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 14:311-315 (Pubitemid 30311512)
5. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young Jr WF 2000 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-2859
6. Nishikawa T, Saito J, Omura M 2007 Is primary aldosteronism rare or common among hypertensive patients? Hypertens Res 30:103-104
7. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-2300
8. Young Jr WF 1999 Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev 7:207-214 (Pubitemid 29316248)
9. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F 2002 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40:897-902 (Pubitemid 35434913)
10. Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J 2002 Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxf) 57:457-465 (Pubitemid 35221345)
11. Fiad TM, Cunningham SK, Hayes FJ, McKenna TJ 1997 Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. J Clin Endocrinol Metab 82:457-460
12. Mitnick PD, Greenberg A, DeOreo PB, Weiner BM, Coffman TM, Walker BR, Agus ZS, Goldfarb S 1980 Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney. Clin Pharmacol Ther 28:680-689
13. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ 2001 Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2:156-169
14. Stowasser M, Gordon RD 2004 The aldosterone-renin ratio in screening for primary aldosteronism. Endocrinologist 14:267-276 (Pubitemid 39232121)
15. Stowasser M, Gordon RD, Klemm SA, Tunny TJ 1993 Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis. J Clin Endocrinol Metab 77:800-804 (Pubitemid 23298670)
16. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin- aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73:952-957 (Pubitemid 21901130)
17. Gordon RD 1995 Primary aldosteronism. J Endocrinol Invest 18: 495-511
18. Gordon RD, Wolfe LK, Island DP, Liddle GW 1966 A diurnal rhythm in plasma renin activity in man. J Clin Invest 45:1587-1592
19. Young WF 2007 Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607-618
20. Gordon RD 2004 The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J Hypertens 22:251-255
21. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M 2006 Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem 52: 1749-1755 (Pubitemid 44330710)
22. Turpeinen U, Hämäläinen E, Stenman UH 2008 Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 862:113-118 (Pubitemid 351173016)
23. Taylor PJ, Cooper DP, Gordon RD, Stowasser M 2009 Measurement of aldosterone in human plasma by semiautomated HPLCtandem mass spectrometry. Clin Chem 55:1155-1162
24. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
25. Hilgenfeldt U, Schwind S 1993 Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy. Am J Physiol 265:E414-E418
26. Ming M, Wu J, Lachance S, Delalandre A, Carrière S, Chan JS 1995 β-Adrenergic receptors and angiotensinogen gene expression in mouse hepatoma cells in vitro. Hypertension 25:105-109
27. Crane MG, Harris JJ 1976 Effect of aging on renin activity and aldosterone excretion. J Lab Clin Med 87:947-959
28. Pizzolo F, Raffaelli R, Memmo A, Chiecchi L, Pavan C, Guarini P, Guidi GC, Franchi M, Corrocher R, Olivieri O 2010 Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. J Hypertens 28:135-142
29. Fuller PJ 2006 Aldosterone: secretion and action. In: DeGroot LJ, Jameson JL, eds. Endocrinology. Philadelphia: Elsevier Saunders; 2319-2328
30. Bühler FR, Laragh JH, Baer L, Vaughan Jr ED, Brunner HR 1972 Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 287:1209-1214
31. Pedersen EB, Kornerup HJ 1975 Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension. Acta Med Scand 198:379-383
32. Stumpe KO, Vetter H, Hessenbruch V, Düsing R, Kolloch R, Krück F 1975 [Effect of chronic β-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)]. Klin Wochenschr 53:907-911 (German)
33. Mazzuco TL, Chaffanjon P, Martinie M, Sturm N, Chabre O 2009 Adrenal Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: prediction of the efficacy of β-blockade therapy and interest of unilateral adrenalectomy. Endocr J 56:867-877
34. Pesant Y, Marc-Aurèle J, Bielmann P, Alaupovic P, Cartier P, Bichet D, Thibault G, Lupien PJ 1999 Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension. Am J Ther 6:137-147
35. Katz FH, Romfh P 1972 Plasma aldosterone and renin activity during the menstrual cycle. J Clin Endocrinol Metab 34:819-821
36. Chidambaram M, Duncan JA, Lai VS, Cattran DC, Floras JS, Scholey JW, Miller JA 2002 Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol 13: 446-452 (Pubitemid 34106287)